Try
AngioDynamics Inc. Common Stock
ANGOUnited States
8 filed reports · 324 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
8 reports · May 2025 to Aug 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 1 operating metrics, 42 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 1,045 | Aug 2025 to Aug 2026 |
| Annual · 10-KSEC EDGAR | 2 | 1,247 | May 2025 to May 2026 |
| Annual · 10-K/ASEC EDGAR | 1 | 50 | May 2026 |
| Current · 8-KSEC EDGAR | 1 | 6 | Aug 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2027 Q1 | 8-K | Aug 31, 2026 | Oct 8, 2026 | 6 | Open |
| FY2027 Q1 | 10-Q | Aug 31, 2026 | Oct 8, 2026 | 369 | Open |
| FY2026 | 10-K/A | May 31, 2026 | Sep 29, 2026 | 50 | Open |
| FY2026 | 10-K | May 31, 2026 | Jul 14, 2026 | 834 | Open |
| FY2026 Q3 | 10-Q | Feb 28, 2026 | Apr 2, 2026 | 278 | Open |
| FY2026 Q2 | 10-Q | Nov 30, 2025 | Jan 6, 2026 | 234 | Open |
| FY2026 Q1 | 10-Q | Aug 31, 2025 | Oct 2, 2025 | 164 | Open |
| FY2025 | 10-K | May 31, 2025 | Jul 18, 2025 | 413 | Open |
Financial data
324 concepts · 2,348 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial313 concepts · 2,157 facts · Oct 2014 to Aug 2026
- Cash cash equivalents restricted cash and restricted cash equivalents17 · May 2022 to Aug 2026
- Stockholders equity (US GAAP)17 · May 2022 to Aug 2026
- 2030 and thereafter16 · May 2025 to May 2026
- Net income loss15 · May 2021 to Aug 2026
- Accrued freight14 · May 2024 to Aug 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value13 · May 2023 to Aug 2026
- Allocated share based compensation expense13 · May 2023 to Aug 2026
- Amortization of intangible assets13 · May 2023 to Aug 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect13 · May 2023 to Aug 2026
- Comprehensive income net of tax13 · May 2023 to Aug 2026
- Cost of goods and services sold (US GAAP)13 · May 2023 to Aug 2026
- Deferred income tax expense benefit13 · May 2023 to Aug 2026
- Depreciation and amortization13 · May 2023 to Aug 2026
- Effect of exchange rate on cash cash equivalents restricted cash and restricted cash equivalents13 · May 2023 to Aug 2026
- Finance lease principal payments13 · May 2023 to Aug 2026
- General and administrative expense (US GAAP)13 · May 2023 to Aug 2026
- Gross profit (US GAAP)13 · May 2023 to Aug 2026
- Income tax expense benefit13 · May 2023 to Aug 2026
- Increase decrease in accounts payable and accrued liabilities13 · May 2023 to Aug 2026
- Increase decrease in accounts receivable13 · May 2023 to Aug 2026
- Increase decrease in inventories13 · May 2023 to Aug 2026
- Increase decrease in prepaid deferred expense and other assets13 · May 2023 to Aug 2026
- Interest income expense nonoperating net13 · May 2023 to Aug 2026
- Legal13 · May 2023 to Aug 2026
Segment4 concepts · 88 facts · May 2023 to Aug 2026
- Cost of goods and services sold (US GAAP)22 · May 2023 to Aug 2026
- Gross profit (US GAAP)22 · May 2023 to Aug 2026
- Med Tech22 · May 2023 to Aug 2026
- Revenue22 · May 2023 to Aug 2026
Product2 concepts · 67 facts · May 2023 to Aug 2026
- Revenue66 · May 2023 to Aug 2026
- Goodwill impairment loss1 · May 2023
Geography1 concepts · 29 facts · May 2023 to Aug 2026
- Revenue29 · May 2023 to Aug 2026
Guidance3 concepts · 6 facts · Oct 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))2 · Oct 2026
- Gross Margin Guidance2 · Oct 2026
- Revenue Guidance2 · Oct 2026
KPI1 concepts · 1 facts · Aug 2026
- Backlog Value1 · Aug 2026
Segments
184 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments2 members · 88 facts
- Med Device44 · May 2023 to Aug 2026
- Med Tech44 · May 2023 to Aug 2026
Product or service2 members · 67 facts
- Med Device34 · May 2023 to Aug 2026
- Med Tech33 · May 2023 to Aug 2026
Statement geographical3 members · 29 facts
- Non Us13 · May 2023 to Aug 2026
- US13 · May 2023 to Aug 2026
- International3 · May 2023 to May 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary8 claims from 1 reports · Aug 2026
- Management discussion (MD&A) commentary49 claims from 3 reports · May 2026 to Aug 2026
Earnings calls
4 calls · Jan 2026 to Oct 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2027 Q1Oct 8, 2026
- FY2026 Q4Jul 14, 2026
- FY2026 Q3Apr 2, 2026
- FY2026 Q2Jan 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.